Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001202452 | SCV001373564 | uncertain significance | Renal carnitine transport defect | 2019-07-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SLC22A5-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 72 of the SLC22A5 protein (p.Arg72Pro). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and proline. |
Natera, |
RCV002226518 | SCV002078280 | uncertain significance | Decreased circulating carnitine concentration | 2020-03-11 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001202452 | SCV002107488 | uncertain significance | Renal carnitine transport defect | 2020-03-11 | no assertion criteria provided | clinical testing |